This company listing is no longer active
R1 RCM Past Earnings Performance
Past criteria checks 2/6
Key information
-42.5%
Earnings growth rate
-26.0%
EPS growth rate
| Healthcare Industry Growth | 15.7% |
| Revenue growth rate | 24.8% |
| Return on equity | 27.5% |
| Net Margin | 6.6% |
| Last Earnings Update | 31 Mar 2022 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How R1 RCM makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 22 | 1,518 | 101 | 123 | 0 |
| 31 Dec 21 | 1,475 | -495 | 120 | 0 |
| 30 Sep 21 | 1,404 | -495 | 116 | 0 |
| 30 Jun 21 | 1,332 | -512 | 108 | 0 |
| 31 Mar 21 | 1,293 | -526 | 103 | 0 |
| 31 Dec 20 | 1,271 | 47 | 103 | 0 |
| 30 Sep 20 | 1,256 | 14 | 102 | 0 |
| 30 Jun 20 | 1,250 | 16 | 105 | 0 |
| 31 Mar 20 | 1,231 | 3 | 108 | 0 |
| 31 Dec 19 | 1,186 | -9 | 105 | 0 |
| 30 Sep 19 | 1,135 | -22 | 106 | 0 |
| 30 Jun 19 | 1,084 | -42 | 107 | 0 |
| 31 Mar 19 | 997 | -41 | 104 | 0 |
| 31 Dec 18 | 869 | -64 | 98 | 0 |
| 30 Sep 18 | 746 | -99 | 84 | 0 |
| 30 Jun 18 | 619 | -88 | 69 | 0 |
| 31 Mar 18 | 510 | -92 | 59 | 0 |
| 31 Dec 17 | 450 | -76 | 56 | 0 |
| 30 Sep 17 | 416 | -28 | 60 | 0 |
| 30 Jun 17 | 418 | -3 | 65 | 0 |
| 31 Mar 17 | 327 | -36 | 71 | 0 |
| 31 Dec 16 | 593 | 65 | 74 | 0 |
| 30 Sep 16 | 555 | 68 | 73 | 0 |
| 30 Jun 16 | 445 | 17 | 75 | 0 |
| 31 Mar 16 | 458 | 35 | 78 | 0 |
| 31 Dec 15 | 117 | -84 | 75 | 0 |
| 30 Sep 15 | 96 | -107 | 77 | 0 |
| 30 Jun 15 | 171 | -65 | 72 | 0 |
Quality Earnings: 6HL has a large one-off loss of $43.1M impacting its March 31 2022 financial results.
Growing Profit Margin: 6HL became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 6HL has become profitable over the past 5 years, growing earnings by -42.5% per year.
Accelerating Growth: 6HL has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: 6HL has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (44.5%).
Return on Equity
High ROE: Whilst 6HL's Return on Equity (27.5%) is high, this metric is skewed due to their high level of debt.